Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(5): 1105-1115, 2023 02 10.
Article
in En
| MEDLINE
| ID: mdl-36288547
Full text:
1
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Adolescent
/
Adult
/
Humans
Language:
En
Journal:
J Clin Oncol
Year:
2023
Type:
Article
Affiliation country:
Colombia